세계의 캡슐 내시경 시장 규모, 점유율, 동향 분석 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Capsule Endoscopy Market Growth & Trends:

The global capsule endoscopy market size is expected to reach USD 695.4 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a compounded annual growth rate (CAGR) of 7.9% from 2025 to 2030. The rising prevalence of colorectal cancer, gastrointestinal diseases, and other intestinal disorders is one of the major factors supporting market growth. In addition, the growing demand for accurate, faster, and precise diagnostic tools coupled with favorable government initiatives are some of the other factors boosting the market growth.

Based on the product, the wireless capsule segment dominated the market in 2023 and is anticipated to register a significant growth rate over the forecast period. It is attributed to the rising utilization rates of capsule endoscopes for the screening of the esophagus, colon, and small intestine in recent years. In addition, the introduction of technologically advanced wireless capsules along with the presence of affirmative reimbursement policies are likely to drive the growth of the segment in the coming years.

Capsule endoscopes are further divided into the type of small bowel, esophageal, and colon. In 2020, the small bowel endoscopy capsules segment held the largest revenue share of 72.3%. This share is attributable to the benefits provided by these devices in the diagnosis and treatment of diseases such as inflammatory bowel disease, Obscure GI Tract Bleeding (OGIB), Crohn's disease, and small bowel neoplastic lesions. In addition, the growing prevalence of these conditions that would require the utilization of small bowel capsules for diagnosis is anticipated to support market growth during the forecast period.

Based on application, in 2024, the OGIB segment accounted for the largest revenue share of 45.4% in the market owing to the advantages provided by this endoscopy in the detection of obscure GI tract bleeding, such as real-time visualization of the small intestine and precise and faster diagnosis. In addition, shifting preference toward capsule-based endoscopic screening as compared to traditional screening for OGIB is yet another prominent factor boosting the market growth.

In 2024, based on end-use, the hospitals segment accounted for the largest revenue share of 55.3%. It is due to the rising adoption and utilization of capsule endoscopes and endoscopy systems in hospitals. In addition, supportive reimbursement policies provided by healthcare institutions as well as the government is further boosting the market growth. Furthermore, since hospitals are the primary healthcare facilities that are opted by patients in many countries across the globe, the number of surgical procedures performed in hospitals is higher and this signifies higher growth potential.

North America dominated the market and accounted for the largest revenue share of 43.6% in 2024. This high share is attributable to factors, such as increasing adoption of technologically advanced capsule-based endoscopy products and systems, rising preference for minimally invasive surgeries, and better-quality healthcare systems and infrastructures. Furthermore, the growing prevalence of chronic conditions, such as gastrointestinal disorders, OGIB, and cancer, are other factors boosting the market growth.

The pandemic of COVID-19 has significantly impacted the market majorly due to the rescheduling, postponement, or cancellation of elective surgeries. In addition, supply chain disruptions and changes in the regulatory scenario for curbing the infection caused due to the COVID-19 virus are other factors that have hindered the market growth during the COVID-19 pandemic. Furthermore, the training of medical professionals for capsule endoscopy was restricted due to the pandemic. According to a 2021 article published in BMJ Journals, some of the institutions have undertaken e-learning modules for capsule endoscopy training due to pandemic situations and are planning to move to traditional training patterns post-pandemic.

Capsule Endoscopy Market Report Highlights:

• The market is anticipated to be valued at USD 695.4 million by 2030, owing to the growing demand for accurate, faster, and precise diagnostic tools coupled with the rising prevalence of colorectal cancer, gastrointestinal diseases, and other intestinal disorders
• The colon capsule endoscopy segment is anticipated to grow at the fastest CAGR over the forecast period, owing to the increasing awareness regarding colon cancer and the emphasis on increasing colon screening in several countries across the world
• In 2024, the Obscure GI Tract Bleeding (OGIB) segment accounted for the highest revenue share in the market due to the advantages of capsule endoscopy in the detection of obscure GI tracts bleeding, such as real-time visualization of the small intestine and faster diagnosis
• The hospitals segment accounted for the highest revenue share due to the large utilization and adoption of capsule endoscopy in hospital systems and favorable reimbursement policies
• North America accounted for the largest revenue share of the market in 2024 due to various factors such as the increasing adoption of technologically advanced capsule-based endoscopy products and systems and rising preference for minimally invasive surgeries

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Segment scope
  • 1.1.2. Regional scope
  • 1.1.3. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
• 1.7. Research Assumptions
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Capsule Endoscopy Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
  • 3.2.2. Market restraint analysis
• 3.3. Capsule Endoscopy: Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
  • 3.3.2. PESTLE Analysis
• 3.4. Capsule Endoscopes Market, Volume Estimates, by Application, 2018 - 2023 (000' Units)
• 3.5. Timeline of Major Milestones in the Development of Wireless Capsule Endoscopy Robots
• 3.6. Pricing Analysis
• 3.7. Case Study Analysis

Chapter 4. Capsule Endoscopy Market Segment Analysis, By Type, 2018-2030 (USD Million)

• 4.1. Definition and Scope
• 4.2. Type Market Share Analysis, 2024 & 2030
• 4.3. Segment Dashboard
• 4.4. Global Capsule Endoscopy Market, by Type, 2018 to 2030
• 4.5. Small Bowel Capsule Endoscopy
  • 4.5.1. Small Bowel Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Esophageal Capsule Endoscopy
  • 4.6.1. Esophageal Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Colon Capsule Endoscopy
  • 4.7.1. Colon Capsule Endoscopy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Capsule Endoscopy Market Segment Analysis, By Application, 2018-2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Application Market Share Analysis, 2024 & 2030
• 5.3. Segment Dashboard
• 5.4. Global Capsule Endoscopy Market, by Application, 2018 to 2030
• 5.5. OGIB (obscure GI tract bleeding)
  • 5.5.1. OGIB (obscure GI tract bleeding) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Crohn's disease
  • 5.6.1. Crohn's disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Small Intestine tumor
  • 5.7.1. Small Intestine tumor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Others (Celiac,NSAID reactions)
  • 5.8.1. Others (Celiac,NSAID reactions) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Capsule Endoscopy Market Segment Analysis, By End Use, 2018-2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. End Use Market Share Analysis, 2024 & 2030
• 6.3. Segment Dashboard
• 6.4. Global Capsule Endoscopy Market, by End Use, 2018 to 2030
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Outpatient Facilities
  • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Capsule Endoscopy Market Segment Analysis, By Region, 2018- 2030 (USD Million)

• 7.1. Regional Market Share Analysis, 2024 & 2030
• 7.2. Regional Market Dashboard
• 7.3. Regional Market Snapshot
• 7.4. Capsule Endoscopy Market Share by Region, 2024 & 2030:
• 7.5. North America
  • 7.5.1. North America capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Regulatory Scenario
    • 7.5.2.3. Competitive Scenario
    • 7.5.2.4. U.S. capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Regulatory Scenario
    • 7.5.3.3. Competitive Scenario
    • 7.5.3.4. Canada capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Regulatory Scenario
    • 7.5.4.3. Competitive Scenario
    • 7.5.4.4. Mexico capsule endoscopy market, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Regulatory Scenario
    • 7.6.2.3. Competitive Scenario
    • 7.6.2.4. UK capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Regulatory Scenario
    • 7.6.3.3. Competitive Scenario
    • 7.6.3.4. Germany capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Regulatory Scenario
    • 7.6.4.3. Competitive Scenario
    • 7.6.4.4. France capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Regulatory Scenario
    • 7.6.5.3. Competitive Scenario
    • 7.6.5.4. Italy capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Regulatory Scenario
    • 7.6.6.3. Competitive Scenario
    • 7.6.6.4. Spain capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.7. Norway
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Regulatory Scenario
    • 7.6.7.3. Competitive Scenario
    • 7.6.7.4. Norway capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Regulatory Scenario
    • 7.6.8.3. Competitive Scenario
    • 7.6.8.4. Sweden capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.6.9. Denmark
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Regulatory Scenario
    • 7.6.9.3. Competitive Scenario
    • 7.6.9.4. Denmark capsule endoscopy market, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Japan
    • 7.7.1.1. Key Country Dynamics
    • 7.7.1.2. Regulatory Scenario
    • 7.7.1.3. Competitive Scenario
    • 7.7.1.4. Japan capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.7.2. China
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Regulatory Scenario
    • 7.7.2.3. Competitive Scenario
    • 7.7.2.4. China capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.7.3. India
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Regulatory Scenario
    • 7.7.3.3. Competitive Scenario
    • 7.7.3.4. India capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.7.4. Australia
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Regulatory Scenario
    • 7.7.4.3. Competitive Scenario
    • 7.7.4.4. Australia capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Regulatory Scenario
    • 7.7.5.3. Competitive Scenario
    • 7.7.5.4. South Korea capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.7.6. Thailand
    • 7.7.6.1. Thailand capsule endoscopy market, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Brazil
    • 7.8.1.1. Key Country Dynamics
    • 7.8.1.2. Regulatory Scenario
    • 7.8.1.3. Competitive Scenario
    • 7.8.1.4. Brazil capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.8.2. Argentina
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Regulatory Scenario
    • 7.8.2.3. Competitive Scenario
    • 7.8.2.4. Argentina capsule endoscopy market, 2018 - 2030 (USD Million)
• 7.9. MEA
  • 7.9.1. South Africa
    • 7.9.1.1. Key Country Dynamics
    • 7.9.1.2. Regulatory Scenario
    • 7.9.1.3. Competitive Scenario
    • 7.9.1.4. South Africa capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.9.2. Saudi Arabia
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Regulatory Scenario
    • 7.9.2.3. Competitive Scenario
    • 7.9.2.4. Saudi Arabia capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.9.3. UAE
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Regulatory Scenario
    • 7.9.3.3. Competitive Scenario
    • 7.9.3.4. UAE capsule endoscopy market, 2018 - 2030 (USD Million)
  • 7.9.4. Kuwait
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Regulatory Scenario
    • 7.9.4.3. Competitive Scenario
    • 7.9.4.4. Kuwait capsule endoscopy market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Profiles
  • 8.3.1. Olympus
    • 8.3.1.1. Company overview
    • 8.3.1.2. Financial performance
    • 8.3.1.3. Platform benchmarking
    • 8.3.1.4. Strategic initiatives
  • 8.3.2. CapsoVision
    • 8.3.2.1. Company overview
    • 8.3.2.2. Financial performance
    • 8.3.2.3. Platform benchmarking
    • 8.3.2.4. Strategic initiatives
  • 8.3.3. Shangxian Minimal Invasive Inc.
    • 8.3.3.1. Company overview
    • 8.3.3.2. Financial performance
    • 8.3.3.3. Platform benchmarking
    • 8.3.3.4. Strategic initiatives
  • 8.3.4. Medtronic
    • 8.3.4.1. Company overview
    • 8.3.4.2. Financial performance
    • 8.3.4.3. Platform benchmarking
    • 8.3.4.4. Strategic initiatives
  • 8.3.5. INTROMEDIC
    • 8.3.5.1. Company overview
    • 8.3.5.2. Financial performance
    • 8.3.5.3. Platform benchmarking
    • 8.3.5.4. Strategic initiatives
  • 8.3.6. AnX Robotics
    • 8.3.6.1. Company overview
    • 8.3.6.2. Financial performance
    • 8.3.6.3. Platform benchmarking
    • 8.3.6.4. Strategic initiatives
  • 8.3.7. JINSHAN Science & Technology (Group) Co., Ltd.
    • 8.3.7.1. Company overview
    • 8.3.7.2. Financial performance
    • 8.3.7.3. Platform benchmarking
    • 8.3.7.4. Strategic initiatives
  • 8.3.8. Check-Cap
    • 8.3.8.1. Company overview
    • 8.3.8.2. Financial performance
    • 8.3.8.3. Platform benchmarking
    • 8.3.8.4. Strategic initiatives
  • 8.3.9. RF Co., Ltd.
    • 8.3.9.1. Company overview
    • 8.3.9.2. Financial performance
    • 8.3.9.3. Platform benchmarking
    • 8.3.9.4. Strategic initiatives
  • 8.3.10. BioCam
    • 8.3.10.1. Company overview
    • 8.3.10.2. Financial performance
    • 8.3.10.3. Platform benchmarking
    • 8.3.10.4. Strategic initiatives